199 related articles for article (PubMed ID: 7590442)
1. Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.
Núñez L; Amigo L; Mingrone G; Rigotti A; Puglielli L; Raddatz A; Pimentel F; Greco AV; González S; Garrido J
Gut; 1995 Sep; 37(3):422-6. PubMed ID: 7590442
[TBL] [Abstract][Full Text] [Related]
2. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids.
Núñez L; Amigo L; Rigotti A; Puglielli L; Mingrone G; Greco AV; Nervi F
FEBS Lett; 1993 Aug; 329(1-2):84-8. PubMed ID: 8102610
[TBL] [Abstract][Full Text] [Related]
4. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
5. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
[TBL] [Abstract][Full Text] [Related]
6. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid bile acid conjugates (FABACs)--new molecules for the prevention of cholesterol crystallisation in bile.
Gilat T; Somjen GJ; Mazur Y; Leikin-Frenkel A; Rosenberg R; Halpern Z; Konikoff F
Gut; 2001 Jan; 48(1):75-9. PubMed ID: 11115826
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium.
Miquel JF; Moreno M; Amigo L; Molina H; Mardones P; Wistuba II; Rigotti A
Gut; 2003 Jul; 52(7):1017-24. PubMed ID: 12801960
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N.
Offner GD; Gong D; Afdhal NH
Gastroenterology; 1994 Mar; 106(3):755-62. PubMed ID: 7907074
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gall bladder bile and endoscopically obtained duodenal bile.
Janowitz P; Swobodnik W; Wechsler JG; Zöller A; Kuhn K; Ditschuneit H
Gut; 1990 Dec; 31(12):1407-10. PubMed ID: 2265783
[TBL] [Abstract][Full Text] [Related]
12. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
[TBL] [Abstract][Full Text] [Related]
13. Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.
Makino I; Chijiiwa K; Higashijima H; Nakahara S; Kishinaka M; Kuroki S; Mibu R
Gut; 1994 Dec; 35(12):1760-4. PubMed ID: 7829016
[TBL] [Abstract][Full Text] [Related]
14. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
Ruppin DC; Murphy GM; Dowling RH
Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
[TBL] [Abstract][Full Text] [Related]
15. Isolation and purification of human biliary vesicles with potent cholesterol-nucleation-promoting activity.
Miquel JF; Rigotti A; Rojas E; Brandan E; Nervi F
Clin Sci (Lond); 1992 Feb; 82(2):175-80. PubMed ID: 1311655
[TBL] [Abstract][Full Text] [Related]
16. Biliary lipid composition in cholesterol microlithiasis.
Fracchia M; Pellegrino S; Secreto P; Gallo L; Masoero G; Pera A; Galatola G
Gut; 2001 May; 48(5):702-6. PubMed ID: 11302972
[TBL] [Abstract][Full Text] [Related]
17. Effect of endoscopic sphincterotomy on gall bladder bile lithogenicity and motility.
Sharma BC; Agarwal DK; Baijal SS; Negi TS; Choudhuri G; Saraswat VA
Gut; 1998 Feb; 42(2):288-92. PubMed ID: 9536957
[TBL] [Abstract][Full Text] [Related]
18. [Influence of efferent biliary ducts on the composition of bile acids. Studies on subjects with cholesterol gall stones and a stone-free control group].
Brühl W
Z Gastroenterol; 1975 Dec; 13(8):690-4. PubMed ID: 1224757
[TBL] [Abstract][Full Text] [Related]
19. Biliary lipid secretion: immunolocalization and identification of a protein associated with lamellar cholesterol carriers in supersaturated rat and human bile.
Rigotti A; Núñez L; Amigo L; Puglielli L; Garrido J; Santos M; González S; Mingrone G; Greco A; Nervi F
J Lipid Res; 1993 Nov; 34(11):1883-94. PubMed ID: 7903346
[TBL] [Abstract][Full Text] [Related]
20. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
Lanzini A; Northfield TC
Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
